UK-China Collaboration to Tackle Antimicrobial Resistance
Funder and programme:
Department of Health and Social Care (DHSC) (with Innovate UK and Chinese Ministry of Science and Technology (MoST)) – Global AMR Innovation Fund (GAMRIF) and DHSC Global Health Security Programme
Project total costs (range):
£ 850,000 – £ 1,200,000
30/05/2018 (12:00 noon)
06/06/2018 (12:00 noon)
The Department of Health and Social Care (DHSC) is working with Innovate UK to invest up to £10 million of Official Development Assistance (ODA) funding. This will be in bilateral research and development (R&D) projects between the UK and China. The funding will address the growing threat of antimicrobial resistance (AMR).
This competition is for innovative projects that support the development and, where appropriate, clinical evaluation of new products or services. These products or services must be of value in addressing the threat from AMR. The Chinese Ministry of Science and Technology (MoST) will invest up to 60 million RMB to fund the Chinese partners.
UK applicants must demonstrate that projects are primarily and directly relevant to the needs of people in low and middle income countries (LMICs), including China, as defined by the Organisation for Economic Co-operation and Development (OECD). There must be a clear economic and societal benefit to LMICs from their proposed project.
DHSC expects total UK project costs of between £850,000 and £1.2 million, giving rise to a total UK grant of no more than £750,000, shared among UK consortium members. Projects can last up to 36 months.
MSC R&D can help your business develop by supporting you in:
• Identification of appropriate grants and competition calls for proposals
• Partner search for collaborative Research & Innovation
• Bid writing
• Project management
• Audit compliance
• Business Planning
• Market Intelligence reports
If you want help with any of these opportunities, please CONTACT us on 0114 230 8401 or email email@example.com